The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2022

Filed:

Jul. 21, 2017
Applicant:

Kolon Life Science, Inc., Seoul, KR;

Inventors:

Sujeong Kim, Seoul, KR;

Minjung Kim, Seoul, KR;

Heonsik Choi, Seoul, KR;

Jaeil Shin, Seoul, KR;

Minju Kim, Seoul, KR;

Hyesun Lee, Seoul, KR;

Soondong Lee, Gwangmyeong-si, KR;

Hwanjun Choi, Incheon, KR;

Joonsung Kim, Gimpo-si, KR;

Jieun Hong, Seoul, KR;

Eunjin Lee, Seoul, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/275 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01); A61K 35/768 (2015.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 35/768 (2013.01); A61K 39/0011 (2013.01); A61P 35/00 (2018.01); C12N 7/00 (2013.01); A61K 2039/525 (2013.01); A61K 2039/585 (2013.01); C12N 2710/24121 (2013.01); C12N 2710/24134 (2013.01);
Abstract

The present invention relates to a recombinant vaccinia virus in which the expression of some genes is inhibited, and a use thereof. The recombinant vaccinia virus of the present invention selectively kills cancer cells, and has an excellent reproducibility in cancer cells. Also, the virus has a lower toxicity to normal cells, and thus has an advantage of being safe for a human body. Therefore, the recombinant vaccinia virus of the present invention can be effectively used as a composition for treating cancer.


Find Patent Forward Citations

Loading…